Search

everythinglearnresearchcommunity

for

Search:↓

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

SLE and DM can coexist but are rare and need careful evaluation.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

Higher leptin levels link to hair loss.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Skin may help in getting rid of excess iron through the process of skin cell renewal.

Two patients had a rare combination of red skin spots and white scaly skin lesions not on the genitals.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Early diagnosis and treatment of calcinosis cutis in lupus patients is crucial due to its rarity and potential complications.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.